Checkmate Theraputics
Seoul
About Checkmate Theraputics
Checkmate Therapeutics is a biotech company that discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2020)
- Website: checkmatetx.com
- Phone: +82-2-723-1911
Industries & Categories
Biotechnology, Oncology
Canonical: https://fsome.com/organization/checkmate-theraputics-54902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.